Updates in NMOSD and MOGAD Diagnosis and Treatment
Neurologic Clinics · 2024-02 · 42 (1) · 77-114
DOI: 10.1016/j.ncl.2023.06.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurologic Clinics, 2024-02. Verfasst von Laura Cacciaguerra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Neuromyelitis Optica, Central Nervous System Diseases. Die Arbeit wurde bisher 106-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder (AQP4+NMOSD) and myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are antibody-associated diseases targeting astrocytes and oligodendrocytes, respectively. Their recognition as distinct entities has led to each having its own diagnostic criteria that require a combination of clinical, serologic, and MRI features. The therapeutic approach to acute attacks in AQP4+NMOSD and MOGAD is similar. There is now class 1 evidence to support attack-prevention medications for AQP4+NMOSD. MOGAD lacks proven treatments although clinical trials are now underway. In this review, we will outline similarities and differences between AQP4+NMOSD and MOGAD in terms of diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.
- Department of Neurology, Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA; Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: Flana…
Förderung
- NINDS NIH HHS
Zitieren
APA
Cacciaguerra, L., & Flanagan, E. P. (2024). Updates in NMOSD and MOGAD Diagnosis and Treatment. Neurologic Clinics, 42(1), 77-114. https://doi.org/10.1016/j.ncl.2023.06.009
Vancouver
Cacciaguerra L, Flanagan EP. Updates in NMOSD and MOGAD Diagnosis and Treatment. Neurologic Clinics. 2024;42(1):77-114. doi:10.1016/j.ncl.2023.06.009
BibTeX
@article{Cacciaguerra2024,
author = {Cacciaguerra, Laura and Flanagan, Eoin P},
title = {Updates in NMOSD and MOGAD Diagnosis and Treatment},
journal = {Neurologic Clinics},
year = {2024},
volume = {42},
number = {1},
pages = {77--114},
doi = {10.1016/j.ncl.2023.06.009}
}
EUVIMED